OBJECTIVES: Both robotic-assisted thoracic surgery (RATS) and uniportal video-assisted thoracic surgery (UVATS) are minimally invasive surgical techniques used for treatment of lung cancer. However, no research studies comparing early outcomes between RATS and UVATS have been reported.
INTRODUCTION
Minimally invasive surgery is the current trend in treatment of non-small-cell lung cancer (NSCLC). Since the 1990s, videoassisted thoracic lobectomy has developed into a mature technology [1, 2] , and its benefits, including lower complication rates, less postoperative pain and shorter hospital stay, compared with open thoracotomy, have been demonstrated [3] [4] [5] . The da Vinci robotic system has recently been introduced into the field of thoracic surgery after its evolution innovated the treatment of urologic and gynaecologic cancers during the rapid development of minimally invasive surgery technology. In 2002, Melfi et al. [6] first reported the application of robotic-assisted thoracic surgery (RATS) for lobectomy. Compared with open surgery, RATS has the advantage of high-definition 3D views and its flexibly controllable robotic platform, which reduces trauma and perioperative morbidity. Several studies have shown the safety and feasibility of RATS for NSCLC treatment [7] [8] [9] .
Uniportal video-assisted thoracic surgery (UVATS) has also evolved similarly over the past decade. In 2011, Gonzalez et al. [10] reported the application of UVATS for lobectomy in lung cancer patients. Using UVATS technique, only a small incision without rib spreading is needed in lobectomy or segmentectomy. With the accumulation of experience, UVATS is confirmed as a safe approach with similar clinical outcomes compared with conventional video-assisted thoracic surgery (VATS) and has now also been used in complex thoracic surgery [11] [12] [13] .
RATS and UVATS are currently only performed in certain centres by professional surgeons. Although several studies comparing conventional VATS to UVATS or RATS have been published, a comparison between RATS and UVATS has not been reported. Thus, this study retrospectively analysed NSCLC cases admitted for RATS or UVATS treatment in our institution.
MATERIALS AND METHODS

Study population
UVATS was carried out in our institution from January 2015 to May 2015. After that, our institution began the RATS programme. Patients admitted for anatomical lobectomy or segmentectomy using RATS or UVATS were included in this study (Fig. 1) . All patients were suitable for lung surgery without severe comorbidity or preoperative chemoradiotherapy. The choice of surgical method was based on the principle of voluntary choice in patients. Patients admitted for R0 resection and radical lymph node (LN) dissection were pathologically confirmed as suffering from NSCLC. Informed consent was obtained from each patient before beginning this study. Finally, a total of 153 patients were enrolled. The data collection included age, gender, surgical site, blood loss, total number of dissected LNs, number of dissected LN station, length of postoperative hospital stay, chest tube duration and perioperative complications. This study was approved by the institutional review board at our centre.
Surgical technique
All patients received general anaesthesia with double-lumen endotracheal intubation. RATS was performed using the da Vinci Si surgical robot (Intuitive Surgical, Inc., Santa Clara, CA, USA) with 3 arms and a camera. We placed 5 ports in the following positions: a 12-mm camera port was placed in the 8th intercostal space (ICS) at the midaxillary line, then three 8-mm working ports were placed separately in the 5th ICS at the anterior axillary line, Arm 1), 8th ICS at posterior axillary line, Arm 2) and the 8th ICS, which was placed 2-cm laterally to the spine, Arm 3). Finally, an auxiliary port was created in the 8th ICS between the camera and the anterior ports.
UVATS was performed using a 4-cm incision in the 5th ICS anterior axillary line. All surgical instruments were placed through this incision without rib spreading.
All surgeries were carried out by the same surgeon who had already performed over 300 conventional VATS lobectomies before the RATS and UVATS techniques were launched.
Statistical analysis
To minimize the bias caused by non-randomized allocation of patients, a retrospective propensity score-matched (PSM) analysis was performed to control the confounding variables. R Project software (v. 2.141; http://www.R-project.org) was used to calculate the propensity score with a multivariable logistic regression model including age, gender, tumour size and operative procedure. The difference of propensity score was within 0.05. SPSS software (v.17.0 for Windows; SPSS Inc., Chicago, IL, USA) was used for statistical analysis. Continuous variables were expressed as mean value ± standard deviation, whereas categorical variables were expressed as percentages. A comparison between the 2 groups was performed, in which the independent sample ttest and paired t-test were used for continuous variables before and after PSM analysis, respectively. The v 2 test was used for dichotomous variables. The 2-tailed statistical significance was defined as P < 0.05.
RESULTS
Among the 153 involved patients, 76 patients underwent RATS and 77 patients underwent UVATS. After PSM, 69 cases from each group were well matched by a 1:1 PSM algorithm. The demographic data are presented in Table 1 . The distributions of age, gender, forced expiratory volume in 1 s, performance status, tumour size, tumour location, operative procedure and pathology stage were similar between the 2 groups before and after PSM. The 30-day mortality was zero in either group. The overall complication rate was 3.9%, which mainly included prolonged air leak, pleural effusion and pneumonia. No severe arrhythmia or postoperative bleeding occurred. Patients who complained of significant postoperative pain received an injection of pethidine. Table 2 presents an analysis of early outcomes before PSM that revealed no significant differences between RATS and UVATS, including operative time (150.24 min vs 136.92 min, P = 0.223), chest tube duration (1.91 days vs 1.77 days, P = 0.254), postoperative hospital stay (4.05 days vs 3.70 days, P = 0.201), overall complication rate (2.6% vs 5.2%, P = 0.681) and postoperative analgesic usage (47.4% vs 41.6%, P = 0.517). The median number of LNs dissected was similar between the 2 groups (11.62 vs 11.05, P = 0.506). Compared with the UVATS group, however, RATS caused less blood loss (80.84 ml vs 110.66 ml, P = 0.015) and more LN stations were dissected (5.79 vs 5.12, P = 0.002). After PSM, the postoperative outcomes demonstrated that RATS had a less significant blood loss (81.73 ml vs 109.63 ml, P = 0.037) and more LN stations dissected (5.86 vs 5.16, P = 0.014).
We investigated the yield of LN dissection further. The results showed that RATS had dissected more N1-level LNs (Fig. 2) , especially in the lobar station (American Thoracic Society Station 12, P < 0.001). The segmental LNs (No. 13) were dissected only in patients who underwent segmentectomy. However, there was no significant difference in the number of N2-level LNs dissected between the 2 groups.
DISCUSSION
To our knowledge, this is the first study to compare the perioperative outcomes between RATS and UVATS for NSCLC treatment. In this study, the patients from each group shared similar preoperative characteristics, disease stage and almost identical early outcomes. Without severe complications, such as bronchopleural fistula, massive haemorrhage or cardiovascular disease, all postoperative complications in our study were either prolonged air leaks or pneumonia. The complication rate was 2.6% in the RATS group and 5.2% in the UVATS group, which showed the clear advantages of both minimal approaches to anatomical lung resection. The only difference we observed was that RATS had less blood loss and the mean number of LN stations dissected was greater. Concerning the blood loss, the most logical explanation is that the high-definition 3D visualization, wristed instrumentation with tremor filtering and motion scaling of the da Vinci robotic system could enable more precise dissection to reduce tissue damage. Jang et al. [14] also reported that intraoperative blood loss in the RATS group was much less than that in the VATS group. Despite this, there were no significant differences in the chest tube duration time and postoperative hospital stay between the 2 surgical methods, and the complication rates for both groups were quite low. Therefore, we considered that the small difference in blood loss did not have a substantial impact on the short-term outcomes.
Although the apparent advantages of RATS and UVATS have been reported in many studies [8, 9, [15] [16] [17] , they have also some potential drawbacks. The da Vinci robotic system lacks tactile feedback during suturing and tissue manipulation, and it is significantly more expensive than VATS, which is related to the greater disposable expenses of the robotic platform and the initial capital expenditure for the robotic system. In comparison, the impaired vision and limited manoeuvrability with UVATS make the LN dissections relatively more difficult [18] . As we know, thorough dissection of LNs is important for anatomical resection in NSCLC because of its impact on staging and recurrence. Some studies demonstrated that VATS was inferior in LN dissection due to the long learning curve of procedure [19, 20] . Our research showed that there were no significant differences in the mediastinal LN dissection in RATS and UVATS; however, more lobar LNs were harvested in the RATS group, although the number of LNs dissected did not reach statistical significance between the 2 groups. We considered that RATS has the advantage of handling LN dissection at any angle of visual field due to the flexible arms of the robotic system. Louie et al. [21] reported more N1-level LNs dissected with RATS, which gave surgeons greater confidence in dissecting N1 LNs adjacent to the pulmonary artery. Cerfolio et al. [22] and Veronesi et al. [23] consistently showed that even in their early experience with RATS, it allowed dissection of LNs to an extent comparable to thoracotomy. Certainly, the apparent improvement in dissection of N1 nodes may merely reflect the fact that the surgeon removed the nodes and labelled them as separate specimens. However, UVATS resects the same nodes with specimens that may not be labelled as diligently by the pathologist. Remarkably, our study showed no significant differences in nodal upstaging between RATS and UVATS, and the number of nodepositive patients in the UVATS group was 2-fold that in RATS (12 vs 6, P = 0.347). In contrast, Wilson et al. [24] reported that robotic resection was superior to VATS in the rate of nodal upstaging, which is similar to thoracotomy. Therefore, the oncological efficacy of RATS and UVATS still needs to be evaluated. Although both techniques are minimally invasive, a criticism against RATS stated that RATS requires 4 or 5 incisions, but UVATS needs only 1 incision. Some investigators have postulated that UVATS may convey benefits in terms of postoperative pain. This study is a retrospective study in which postoperative pain was not examined in a standardized fashion; therefore, it is unable to compare the postoperative pain scores. However, the frequency of postoperative analgesic usage was similar in both groups. Young et al. [25] recently performed a review analysing postoperative pain following UVATS and conventional VATS, which was unable to demonstrate that UVATS conferred less postoperative pain compared with conventional VATS. In our own experience, minimally invasive techniques reduce the volume of pleural drainage, which reduces the duration of in situ chest tubes; therefore, postoperative pain would be reduced significantly compared with open surgery. However, this conclusion still needs to be confirmed by more case studies.
Considering its cosmetic effect, UVATS leaves a smaller scar than RATS. However, UVATS also has certain drawbacks such as a long learning curve and limited operation space. It is worth mentioning that 2 patients in the RATS group and 4 patients in the UVATS group required conversion to thoracotomy (RATS versus UVATS, 2.6% vs 5.2%, P = 0.681), and the conversion rate was similar to other studies [21, 26] . These patients were excluded from our cohort because we needed to summarize the normal clinical features of RATS and UVATS. In the RATS group, 2 patients were converted to thoracotomy: one due to uncontrolled bleeding and the other due to diffuse pleural adhesions. In the UVATS group, 3 patients were converted to thoracotomy because of tenacious pleural adhesion and 1 due to massive bleeding. Mungo et al. [27] demonstrated that uncontrolled bleeding is more common in VATS than RATS lobectomies. They also reported that the conversion rate in RATS was lower than that in VATS. In our experience, the better manoeuvrability and the superior vision of the robotic surgery system are helpful to handle pleural adhesions, particularly in the adhesion of the lateral chest wall. RATS could be a good choice for patients with a history of severe pleurisy that could cause diffused pleural adhesion. The shortcoming of this study was its relatively small sample size, which could cause random error. However, in our study, the same surgeon performed all RATS and UVATS procedures accepted by patients during the same time period, which could limit the differences caused by temporal changes in perioperative surgical management. Additionally, the surgeon was experienced in conventional VATS; therefore, the differences we observed were unlikely to be influenced by technical ability, which might be the case if RATS and UVATS were performed by an unskilled surgeon. In addition, PSM analysis could minimize the bias and make the results more persuasive.
Limitations
This study has many limitations due to its retrospective nature. Despite the similarity in the baseline of patients and tumour characteristics, inevitable selection biases could be present. Considering that this research is based on the experience of a single surgeon at a single centre, the results of further expected multicentre studies might be more applicable to the population. Importantly, longitudinal multicentre studies would evaluate not only perioperative outcomes but also tumour recurrence and long-term survival.
CONCLUSION
In conclusion, RATS and UVATS are safe and feasible for NSCLC treatment, in which the early outcomes are similar. Considering that their long-term outcomes are still unclear, larger prospective studies should be undertaken to fully assess the benefit of these surgical technologies.
